Search Results - "Dow, S"

Refine Results
  1. 1

    Immune modulatory effects of tulathromycin, gamithromycin, and oxytetracycline in cattle by Wheat, W, Chow, L, Still-Brooks, K, Moore-Foster, R, Herman, J, Hunter, R, Garry, F, Dow, S

    Published in BMC veterinary research (09-10-2024)
    “…Certain classes of antibiotics, including tetracyclines and macrolides, are known to exert immune suppressive effects in other species but the immune…”
    Get full text
    Journal Article
  2. 2

    PD‐1 expression by canine T cells and functional effects of PD‐1 blockade by Coy, J., Caldwell, A., Chow, L., Guth, A., Dow, S.

    Published in Veterinary & comparative oncology (01-12-2017)
    “…The co‐inhibitory checkpoint molecule programmed death receptor 1 (PD‐1) can trigger T cell functional exhaustion upon binding to its ligand PD‐L1 expressed on…”
    Get full text
    Journal Article
  3. 3

    Checkpoint molecule expression by B and T cell lymphomas in dogs by Hartley, G., Elmslie, R., Dow, S., Guth, A.

    Published in Veterinary & comparative oncology (01-09-2018)
    “…Immunotherapies targeting checkpoint molecule programmed cell death 1 (PD‐1) protein were shown to be effective for treatment of non‐Hodgkin lymphoma in…”
    Get full text
    Journal Article
  4. 4

    A phase II, double blind, placebo-controlled, randomized evaluation of the safety and efficacy of tafenoquine in patients with mild-moderate COVID-19 disease by Dow, G.-S., Smith, B.-L.

    Published in New microbes and new infections (01-04-2022)
    “…The safety and efficacy of tafenoquine administered as a 200 mg dose once per day on days 1, 2, 3, and 10 was evaluated over a 28-day period in mild-moderate…”
    Get full text
    Journal Article
  5. 5

    Long-term evaluation of mesenchymal stem cell therapy in a feline model of chronic allergic asthma by Trzil, J. E., Masseau, I., Webb, T. L., Chang, C.-H., Dodam, J. R., Cohn, L. A., Liu, H., Quimby, J. M., Dow, S. W., Reinero, C. R.

    Published in Clinical and experimental allergy (01-12-2014)
    “…Summary Background Mesenchymal stem cells (MSCs) decrease airway eosinophilia, airway hyperresponsiveness (AHR), and remodelling in murine models of acutely…”
    Get full text
    Journal Article
  6. 6

    Allogeneic vs. autologous intra‐articular mesenchymal stem cell injection within normal horses: Clinical and cytological comparisons suggest safety by Colbath, A. C., Dow, S. W., Hopkins, L. S., Phillips, J. N., McIlwraith, C. W., Goodrich, L. R.

    Published in Equine veterinary journal (01-01-2020)
    “…Summary Background Allogeneic bone marrow‐derived mesenchymal stem cells (BMDMSCs) could provide multiple advantages over autologous BMDMSCs, including…”
    Get full text
    Journal Article
  7. 7

    Metronomic Therapy with Cyclophosphamide and Piroxicam Effectively Delays Tumor Recurrence in Dogs with Incompletely Resected Soft Tissue Sarcomas by Elmslie, R.E., Glawe, P., Dow, S.W.

    Published in Journal of veterinary internal medicine (01-11-2008)
    “…Background: Continuous administration of low doses of cyclophosphamide and standard doses of cyclooxygenase‐inhibiting drugs has been shown to suppress tumor…”
    Get full text
    Journal Article
  8. 8

    Immune regulation of canine tumour and macrophage PD‐L1 expression by Hartley, G., Faulhaber, E., Caldwell, A., Coy, J., Kurihara, J., Guth, A., Regan, D., Dow, S.

    Published in Veterinary & comparative oncology (01-06-2017)
    “…Expression of programmed cell death receptor ligand 1 (PD‐L1) on tumor cells has been associated with immune escape in human and murine cancers, but little is…”
    Get full text
    Journal Article
  9. 9

    Low-Dose Cyclophosphamide Selectively Decreases Regulatory T Cells and Inhibits Angiogenesis in Dogs with Soft Tissue Sarcoma by Burton, J.H., Mitchell, L., Thamm, D.H., Dow, S.W., Biller, B.J.

    Published in Journal of veterinary internal medicine (01-07-2011)
    “…Background: Low‐dose, continuous (metronomic) chemotherapy improves tumor control by inhibiting tumor angiogenesis and suppressing regulatory T cells (Treg) in…”
    Get full text
    Journal Article
  10. 10

    Novel treatment strategies for feline chronic kidney disease: A critical look at the potential of mesenchymal stem cell therapy by Quimby, J.M., Dow, S.W.

    Published in The veterinary journal (1997) (01-06-2015)
    “…•Mesenchymal stem cells are obtained from various tissues and donor attributes have implications for therapeutic potential.•The proposed mechanism of action of…”
    Get full text
    Journal Article
  11. 11

    Diet‐induced obesity causes visceral, but not subcutaneous, lymph node hyperplasia via increases in specific immune cell populations by Magnuson, A. M., Regan, D. P., Fouts, J. K., Booth, A. D., Dow, S. W., Foster, M. T.

    Published in Cell proliferation (01-10-2017)
    “…Objectives The spatial proximity of adipose depots to secondary lymph nodes allows a unique relation between the two systems. Obesity, predominately visceral…”
    Get full text
    Journal Article
  12. 12

    Synthesis and biological evaluation of the first pentafluorosulfanyl analogs of mefloquine by Wipf, Peter, Mo, Tingting, Geib, Steven J, Caridha, Diana, Dow, Geoffrey S, Gerena, Lucia, Roncal, Norma, Milner, Erin E

    Published in Organic & biomolecular chemistry (01-01-2009)
    “…Two novel SF5 analogs of the antimalarial agent mefloquine were synthesized in 5 steps and 10-23% overall yields and found to have improved activity and…”
    Get more information
    Journal Article
  13. 13

    Thermal and electrical properties of silicon nitride substrates by Dow, Hwan Soo, Kim, Woo Sik, Lee, Jung Woo

    Published in AIP advances (01-09-2017)
    “…This work presents the results of studies on the thermal and electrical properties of sintered silicon nitride to investigate the effects of non-oxide…”
    Get full text
    Journal Article
  14. 14

    Learning From Vulnerable Populations: Methodological Implications of Interviewing Individuals With Fetal Alcohol Spectrum Disorder by Dow, Brenda S., Boylan, Brandon M.

    “…Scholars face methodological challenges when conducting research about vulnerable populations, such as individuals living with fetal alcohol spectrum disorder…”
    Get full text
    Journal Article
  15. 15

    Decreased ratio of CD8+ T cells to regulatory T cells associated with decreased survival in dogs with osteosarcoma by Biller, B.J, Guth, A, Burton, J.H, Dow, S.W

    Published in Journal of veterinary internal medicine (01-09-2010)
    “…Background: Increased numbers of regulatory T cells (Treg) and decreased ratios of CD8+ T cells to Treg have been shown to correlate with decreased survival…”
    Get full text
    Journal Article
  16. 16

    Changes in Regulatory T Cells in Dogs with Cancer and Associations with Tumor Type by O'Neill, K, Guth, A, Biller, B, Elmslie, R, Dow, S

    Published in Journal of veterinary internal medicine (01-07-2009)
    “…Background: Regulatory T cells (Treg) have been shown to suppress antitumor immunity and often are increased in humans and rodents with cancer. However, Tregs…”
    Get full text
    Journal Article
  17. 17

    The Persistence and Implications of Japanese Keiretsu Organization by McGuire, J., Dow, S.

    Published in Journal of international business studies (01-07-2003)
    “…This paper examines two important research questions: (1) To what extent have recent economic and regulatory changes influenced the Japanese intercorporate…”
    Get full text
    Journal Article
  18. 18

    Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium : Short- and long-term effects by WANGDE DAI, HALE, Sharon L, MARTIN, Bradley J, KUANG, Jin-Qiang, DOW, Joan S, WOLD, Loren E, KLONER, Robert A

    Published in Circulation (New York, N.Y.) (12-07-2005)
    “…Mesenchymal stem cells (MSCs) have the potential to replace infarct scar, but the long-term effects are unknown. We studied short- and long-term effects of MSC…”
    Get full text
    Journal Article
  19. 19

    Role of monocyte recruitment in hemangiosarcoma metastasis in dogs by Regan, D. P., Escaffi, A., Coy, J., Kurihara, J., Dow, S. W.

    Published in Veterinary & comparative oncology (01-12-2017)
    “…Canine hemangiosarcoma (HSA) is a highly malignant tumour associated with short survival times because of early and widespread metastasis. In humans and…”
    Get full text
    Journal Article
  20. 20

    Wizard of Oz support throughout an iterative design process by Dow, S., MacIntyre, B., Lee, J., Oezbek, C., Bolter, J.D., Gandy, M.

    Published in IEEE pervasive computing (01-10-2005)
    “…The Wizard of Oz prototyping approach, widely used in human-computer interaction research, is particularly useful in exploring user interfaces for pervasive,…”
    Get full text
    Journal Article